https://www.siliconvalley.com/2020/04/23/gilead-disputes-negative-report-on-coronavirus-drug-trial/

By Saumya Joseph and Deena Beasley | Reuters

A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.